GT Biopharma Announces TriKE™ For The Treatment Of Breast And GI Cancers ...Middle East

PR Newswire - News
GT Biopharma Announces TriKE™ For The Treatment Of Breast And GI Cancers
BEVERLY HILLS, Calif., Dec. 28, 2020 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology platform is pleased to announce the filing of U.S. and...

Hence then, the article about gt biopharma announces trike for the treatment of breast and gi cancers was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GT Biopharma Announces TriKE™ For The Treatment Of Breast And GI Cancers )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News